Lunit Files Registration Statement for Initial Public Offering

First Korean healthcare company to obtain "AA-AA" ratings in technology assessment for its FDA-cleared and CE-marked solutions Lunit intends to list its common stock on the KOSDAQ market under the ticker code "A32813". NH Investment & Securities will act as book-running manager, backing Lunit's debut. A total of 1,124,300 shares will be offered in the price range of KRW 44,000 to 49,000 ($34-38). The exact price will be determined after recording the demand of institutional investors on July 7-8, while retail buyers can take part in the public subscription during July 12-13. Based on the low end of the targeted range, Lunit expects to raise about KRW 54 billion ($42 million).